Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

The new gel for hair loss is safe, effective, and reduces side effects.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

High androgen levels can cause hirsutism and increase inflammation.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Excess androgens may cause PCOS, not just be a symptom.

Adding aesthetic therapies to medications doesn't improve male pattern baldness treatment.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Higher sebum levels are linked to more severe male baldness.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

PCOS may be influenced by factors in the blood, not just the ovaries.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.